FNY Investment Advisers’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Hold	0	–	–	–	484
2023 Q3	–	Hold	0	–	–	–	593
2018 Q4	–	Sell	-2,000	Closed	-$57K	–	661
2018 Q3	$57K	Buy	+2,000	New	+$57K	0.01%	338